# Clinical trials recruiting in Arizona: 1,810 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,810 trials recruiting or not yet recruiting with a site in Arizona, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Arizona: 1,810 rows for $90.50, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 34 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/arizona

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,810
- Recruiting or not yet: 1,810
- Read on: November 19, 2026

## Trials

The 25 newest of 1,810, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07940803 | A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 Diabetes | Novo Nordisk A/S | Phase 1/2 | Not yet recruiting | Overweight, Obesity, Type 2 Diabetes Mellitus | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940803) |
| November 16, 2026 | NCT07938320 | Vuse Pro Puffing Topography Study in Adult Smokers | RAI Services Company | Not applicable | Recruiting | Smoking, Tobacco | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938320) |
| November 16, 2026 | NCT07937423 | DYNAMIC Pilot Optimization Trial | H. Lee Moffitt Cancer Center and Research Institute | Not applicable | Not yet recruiting | Advanced Cancer, Metastatic Cancer, Cancer Survivorship | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937423) |
| November 13, 2026 | NCT07935889 | Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 Trial | Mayo Clinic | Phase 3 | Recruiting | Glioblastoma, IDH-Wildtype | 292 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935889) |
| November 12, 2026 | NCT07933822 | Therapy for Adverbial Clauses | University of Arizona | Not applicable | Recruiting | Developmental Language Disorder | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933822) |
| November 12, 2026 | NCT07932613 | Effect of Metaxalone 640 mg (M640) on Driving, Cognition, and EEG Dynamics Compared to Tizanidine 8 mg in Adults | Primus Pharmaceuticals | Phase 4 | Not yet recruiting | Healthy Participant | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932613) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 10, 2026 | NCT07929584 | A Study to Establish the Diagnostic Value of the EPISEEK-MPE Liquid Biopsy Assay to Identify Cancer in Pleural Effusion Samples. | University of Arizona | Observational | Recruiting | Pleural Effusions | 625 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929584) |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 10, 2026 | NCT07927933 | Assessing the Effect of Infant-directed Unidirectional Feeding Valves on Milk Volume Intake in Infants With Cleft Palate | Phoenix Children's Hospital | Not applicable | Recruiting | Cleft Palate, Cleft Palate +/- Lip, Orofacial Cleft | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927933) |
| November 10, 2026 | NCT07927296 | Vinegar and Heartburn | Arizona State University | Not applicable | Recruiting | Heartburn | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927296) |
| November 10, 2026 | NCT07927283 | Fulvic Acid Supplementation and Metabolic Syndrome | Arizona State University | Not applicable | Recruiting | Metabolic Syndrome | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927283) |
| November 9, 2026 | NCT07926594 | Effectiveness Study of TRYPTYR in Dry Eye Disease | Scott & Christie and Associates, PC | Observational | Recruiting | Dry Eye Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926594) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 6, 2026 | NCT07923045 | A Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With Stage I and Stage II Neurotrophic Keratopathy | Viatris Inc. | Phase 1/2 | Recruiting | Neurotrophic Keratopathy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923045) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 4, 2026 | NCT07916311 | POSLUMA PET Imaging for PI-RADS 3 Prostate Lesions | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Prostate Cancer, PI-RADS 3 Prostate Lesion | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916311) |
| November 4, 2026 | NCT07915609 | A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight and/or Obesity, Knee Osteoarthritis, Diabetes Melliuts, Type 2 | 756 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915609) |
| November 4, 2026 | NCT07915557 | Parenting Program for Young Children With Spina Bifida | Phoenix Children's Hospital | Not applicable | Not yet recruiting | Spina Bifida | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915557) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07908316 | Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After... | Amgen | Phase 1 | Recruiting | Obesity, Overweight | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908316) |
| October 30, 2026 | NCT07907991 | The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907991) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Mayo Clinic in Arizona | Scottsdale | 89 |
| University of Arizona | Tucson | 84 |
| Mayo Clinic Arizona | Phoenix | 69 |
| Phoenix Children's Hospital | Phoenix | 64 |
| Mayo Clinic | Scottsdale | 62 |
| Banner MD Anderson Cancer Center | Gilbert | 62 |
| Banner University Medical Center - Tucson | Tucson | 56 |
| Cancer Center at Saint Joseph's | Phoenix | 48 |
| Mayo Clinic Hospital in Arizona | Phoenix | 44 |
| University of Arizona Cancer Center-North Campus | Tucson | 41 |
| Kingman Regional Medical Center | Kingman | 36 |
| Phoenix Childrens Hospital | Phoenix | 33 |
| HonorHealth Research Institute | Scottsdale | 27 |
| University of Arizona Cancer Center | Tucson | 27 |
| Barrow Neurological Institute | Phoenix | 23 |
| Honor Health | Scottsdale | 22 |
| St. Joseph's Hospital and Medical Center | Phoenix | 21 |
| Mayo Clinic Hospital | Phoenix | 20 |
| Arizona State University | Phoenix | 19 |
| Banner University Medical Center | Phoenix | 18 |
| Honor Health Research Institute | Scottsdale | 15 |
| Banner Children's at Desert | Mesa | 15 |
| CTCA at Western Regional Medical Center | Goodyear | 14 |
| The University of Arizona Cancer Center | Tucson | 14 |
| Ironwood Cancer & Research Centers | Chandler | 13 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 19 |
| Phase 1 | 146 |
| Phase 1/2 | 124 |
| Phase 2 | 328 |
| Phase 2/3 | 56 |
| Phase 3 | 540 |
| Phase 4 | 50 |
| Not applicable | 315 |
| Observational | 232 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 77 |
| Breast Neoplasms | 59 |
| Colorectal Neoplasms | 56 |
| Neoplasms | 56 |
| Prostatic Neoplasms | 51 |
| Neoplasm Metastasis | 49 |
| Obesity | 49 |
| Lung Neoplasms | 36 |
| Pancreatic Neoplasms | 35 |
| Overweight | 33 |
| Heart Failure | 32 |
| Multiple Myeloma | 31 |
| Diabetes Mellitus, Type 2 | 29 |
| Melanoma | 28 |
| Cardiovascular Diseases | 27 |
| Endometrial Neoplasms | 27 |
| Ovarian Neoplasms | 25 |
| Leukemia, Myeloid, Acute | 25 |
| Alzheimer Disease | 24 |
| Recurrence | 24 |
| Carcinoma, Renal Cell | 21 |
| Pulmonary Disease, Chronic Obstructive | 21 |
| Urinary Bladder Neoplasms | 20 |
| Squamous Cell Carcinoma of Head and Neck | 19 |
| Crohn Disease | 18 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Mayo Clinic | 99 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 64 |
| University of Arizona | 59 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 56 |
| National Cancer Institute (NCI) | 44 |
| Arizona State University | 30 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 29 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 26 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 24 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 22 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 22 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 21 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 20 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 20 |
| Children's Oncology Group | 20 |
| Alliance for Clinical Trials in Oncology | 19 |
| SWOG Cancer Research Network | 18 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 18 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 17 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 16 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 15 |
| NRG Oncology | 14 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 14 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 13 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 13 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Arizona

- [Plastic manufacturers in Arizona, United States](https://specstream.ai/data/businesses/plastic-manufacturers/arizona-united-states)
- [Real estate firms in Arizona, United States](https://specstream.ai/data/businesses/real-estate-firms/arizona-united-states)
- [Stone suppliers in Arizona, United States](https://specstream.ai/data/businesses/stone-suppliers/arizona-united-states)
- [Vegetarian restaurants in Arizona, United States](https://specstream.ai/data/businesses/vegetarian-restaurants/arizona-united-states)
- [Allergy and immunology practices in Arizona, United States](https://specstream.ai/data/businesses/allergy-and-immunology-practices/arizona-united-states)
- [Bars in Arizona, United States](https://specstream.ai/data/businesses/bars/arizona-united-states)
